Page last updated: 2024-12-04
dansyl acid
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
dansyl acid: fluorescent probe [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 1792 |
SCHEMBL ID | 133520 |
MeSH ID | M0104768 |
Synonyms (34)
Synonym |
---|
5-(dimethylamino)naphthalene-1-sulfonic acid |
STL290518 |
5-(dimethylamino)naphthalene-1-sulphonic acid |
einecs 224-268-5 |
1-naphthalenesulfonic acid, 5-(dimethylamino)- |
dansyl acid |
5-(dimethylamino)-1-naphthalenesulfonic acid(dansyl acid) |
D1426 |
DB07376 |
5-dimethylamino-1-naphthalenesulfonic acid |
4272-77-9 |
bbeqqkbwuhciou-uhfffaoysa- |
inchi=1/c12h13no3s/c1-13(2)11-7-3-6-10-9(11)5-4-8-12(10)17(14,15)16/h3-8h,1-2h3,(h,14,15,16) |
5-dimethylaminonaphthalene-1-sulfonic acid |
AKOS005267186 |
5-(dimethylamino)-1-naphthalenesulfonic acid |
FT-0624415 |
SCHEMBL133520 |
DTXSID8063383 |
BBEQQKBWUHCIOU-UHFFFAOYSA-N |
SR-01000310386-1 |
sr-01000310386 |
mfcd00003995 |
AS-66186 |
1-dimethylaminonaphthalene-5-sulfonic acid |
dansylacid |
Q27096596 |
5-dimethylamino-1-sulfonyl naphthalene |
n,n-dimethyl-1-naphthylamine-5-sulfonic acid |
N10048 |
A872831 |
CS-0313530 |
dansylacid-d6 |
PD005845 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (13)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (7.69) | 18.7374 |
1990's | 1 (7.69) | 18.2507 |
2000's | 5 (38.46) | 29.6817 |
2010's | 3 (23.08) | 24.3611 |
2020's | 3 (23.08) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 28.15
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (28.15) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 13 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |